279 related articles for article (PubMed ID: 26772885)
1. Microfluidic technology enhances the potential of human pluripotent stem cells.
Gagliano O; Elvassore N; Luni C
Biochem Biophys Res Commun; 2016 May; 473(3):683-7. PubMed ID: 26772885
[TBL] [Abstract][Full Text] [Related]
2. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
3. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
Tesarova L; Simara P; Stejskal S; Koutna I
PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
[TBL] [Abstract][Full Text] [Related]
4. High-efficiency cellular reprogramming with microfluidics.
Luni C; Giulitti S; Serena E; Ferrari L; Zambon A; Gagliano O; Giobbe GG; Michielin F; Knöbel S; Bosio A; Elvassore N
Nat Methods; 2016 May; 13(5):446-52. PubMed ID: 27088312
[TBL] [Abstract][Full Text] [Related]
5. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
6. A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells.
Hesari Z; Soleimani M; Atyabi F; Sharifdini M; Nadri S; Warkiani ME; Zare M; Dinarvand R
J Biomed Mater Res A; 2016 Jun; 104(6):1534-43. PubMed ID: 26914600
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic reprogramming to pluripotency of human somatic cells.
Gagliano O; Luni C; Qin W; Bertin E; Torchio E; Galvanin S; Urciuolo A; Elvassore N
Nat Protoc; 2019 Mar; 14(3):722-737. PubMed ID: 30809022
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic systems: a new toolbox for pluripotent stem cells.
Lesher-Perez SC; Frampton JP; Takayama S
Biotechnol J; 2013 Feb; 8(2):180-91. PubMed ID: 23125055
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit.
Sfougataki I; Grafakos I; Varela I; Mitrakos A; Karagiannidou A; Tzannoudaki M; Poulou M; Mertzanian A; Roubelakis G M; Stefanaki K; Traeger-Synodinos J; Kanavakis E; Kitra V; Tzetis M; Goussetis E
Blood Cells Mol Dis; 2019 May; 76():32-39. PubMed ID: 30709626
[TBL] [Abstract][Full Text] [Related]
11. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
12. A circular RNA map for human induced pluripotent stem cells of foetal origin.
Barilani M; Cherubini A; Peli V; Polveraccio F; Bollati V; Guffanti F; Del Gobbo A; Lavazza C; Giovanelli S; Elvassore N; Lazzari L
EBioMedicine; 2020 Jul; 57():102848. PubMed ID: 32574961
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
[TBL] [Abstract][Full Text] [Related]
14. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages.
Zhu L; Gomez-Duran A; Saretzki G; Jin S; Tilgner K; Melguizo-Sanchis D; Anyfantis G; Al-Aama J; Vallier L; Chinnery P; Lako M; Armstrong L
J Cell Biol; 2016 Oct; 215(2):187-202. PubMed ID: 27810911
[TBL] [Abstract][Full Text] [Related]
16. The future of the patient-specific Body-on-a-chip.
Williamson A; Singh S; Fernekorn U; Schober A
Lab Chip; 2013 Sep; 13(18):3471-80. PubMed ID: 23685915
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Retinal Differentiation of Human Induced Pluripotent Stem Cells in a Continuously Perfused Microfluidic Culture Device.
Abdolvand N; Tostoes R; Raimes W; Kumar V; Szita N; Veraitch F
Biotechnol J; 2019 Mar; 14(3):e1800323. PubMed ID: 30155990
[TBL] [Abstract][Full Text] [Related]
18. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes.
Emdad L; D'Souza SL; Kothari HP; Qadeer ZA; Germano IM
Stem Cells Dev; 2012 Feb; 21(3):404-10. PubMed ID: 21631388
[TBL] [Abstract][Full Text] [Related]
19. Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology.
Cochrane A; Albers HJ; Passier R; Mummery CL; van den Berg A; Orlova VV; van der Meer AD
Adv Drug Deliv Rev; 2019 Feb; 140():68-77. PubMed ID: 29944904
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalized microfluidic perfusion system to culture human induced pluripotent stem cell aggregates.
Kondo Y; Hattori K; Tashiro S; Nakatani E; Yoshimitsu R; Satoh T; Sugiura S; Kanamori T; Ohnuma K
J Biosci Bioeng; 2017 Aug; 124(2):234-241. PubMed ID: 28434976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
